You are here

  • Home
  • Archive
  • Volume 23, Issue 4
  • Role of Gefitinib in Patients With Recurrent or Metastatic Cervical Carcinoma Ineligible or Refractory to Systemic Chemotherapy: First Study From Asia

Article metrics

Article menu
Download PDFPDF
Cervical Cancer
Role of Gefitinib in Patients With Recurrent or Metastatic Cervical Carcinoma Ineligible or Refractory to Systemic Chemotherapy: First Study From Asia

 

Online download statistics by month:

Online download statistics by month: January 2019 to September 2023

AbstractFullPdf
Jan 20191602
Feb 20192001
Mar 20197700
Apr 20197802
May 20192601
Jun 20193102
Jul 20194702
Aug 20191400
Sep 20194201
Oct 20191600
Nov 20191000
Dec 20191000
Jan 20201400
Feb 2020800
Mar 2020601
Apr 20202202
May 20202401
Jun 20201600
Jul 20203800
Aug 20202603
Sep 20201400
Oct 20201600
Nov 2020601
Dec 20201800
Jan 20211100
Feb 20212000
Mar 20212501
Apr 20217000
May 2021701
Jun 2021600
Jul 2021100
Oct 20214601
Nov 20215001
Dec 20211600
Jan 20222001
Feb 20221000
Mar 20224800
Apr 20221600
May 20225200
Jun 20227800
Jul 20223601
Aug 20224000
Sep 20225001
Oct 20226400
Nov 20223700
Dec 20222800
Jan 20232400
Feb 20237600
Mar 20231101
Apr 202311100
May 20232200
Jun 20232200
Jul 20231200
Aug 20231600
Sep 20231001
Total1630028